Donor pre-treatment with dopamine reduces injury to the kidney graft with consequences on the
clinical performance immediately after transplantation: Donor dopamine reduces the
requirement of dialysis post transplant, and results in renal function improvements.
The purpose of the study is to investigate the potentially therapeutic impact of donor
preconditioning with low dose dopamine in human renal transplant recipients from a brain dead
donor.
Phase:
Phase 4
Details
Lead Sponsor:
Universitätsmedizin Mannheim
Collaborators:
Eurotransplant International Foundation, Leiden, The Netherlands Novartis Regional Organ Procurement Organization (DSO), Baden-Wuerttemberg, Germany Regional Organ Procurement Organization (DSO), Bavaria, Germany